ATE180168T1 - Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus - Google Patents

Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Info

Publication number
ATE180168T1
ATE180168T1 AT93922725T AT93922725T ATE180168T1 AT E180168 T1 ATE180168 T1 AT E180168T1 AT 93922725 T AT93922725 T AT 93922725T AT 93922725 T AT93922725 T AT 93922725T AT E180168 T1 ATE180168 T1 AT E180168T1
Authority
AT
Austria
Prior art keywords
diabetes mellitus
dependent diabetes
prevent insulin
insulin
prevent
Prior art date
Application number
AT93922725T
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paul J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE180168T1 publication Critical patent/ATE180168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT93922725T 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus ATE180168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (1)

Publication Number Publication Date
ATE180168T1 true ATE180168T1 (de) 1999-06-15

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922725T ATE180168T1 (de) 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (de)
JP (1) JP2739770B2 (de)
KR (1) KR0166663B1 (de)
CN (1) CN1093598A (de)
AT (1) ATE180168T1 (de)
AU (1) AU689448B2 (de)
CA (1) CA2145863A1 (de)
CZ (1) CZ286866B6 (de)
DE (1) DE69325029T2 (de)
DK (1) DK0662837T3 (de)
ES (1) ES2131122T3 (de)
FI (1) FI951511A (de)
GR (1) GR3030269T3 (de)
HK (1) HK1008812A1 (de)
HU (1) HU217871B (de)
IL (1) IL107153A (de)
MX (1) MX9306043A (de)
MY (1) MY111543A (de)
NO (1) NO951240L (de)
SG (1) SG48733A1 (de)
SK (1) SK281806B6 (de)
TW (1) TW336172B (de)
WO (1) WO1994008606A1 (de)
ZA (1) ZA937244B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76101A (en) * 1994-04-08 1997-06-30 Brigham & Womens Hospital Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
WO1996018412A1 (en) * 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
JPH11510185A (ja) * 1995-08-07 1999-09-07 シェーリング コーポレイション インターロイキン−１０を用いた眼の炎症性状態の処置
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
JPH11510806A (ja) * 1995-08-09 1999-09-21 シェーリング コーポレイション 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
AU744577B2 (en) * 1997-10-14 2002-02-28 Mitsubishi Pharma Corporation Piperazine compounds and medicinal use thereof
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
JP6403062B2 (ja) * 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
EP3442562B1 (de) 2016-04-15 2022-09-21 Evive Biotechnology (Shanghai) Ltd Ein il-22-dimer zur verwendung in der behandlung der nekrotisierenden enterokolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
KR950703353A (ko) 1995-09-20
AU689448B2 (en) 1998-04-02
IL107153A (en) 2000-07-16
DE69325029T2 (de) 1999-10-07
TW336172B (en) 1998-07-11
HUT71421A (en) 1995-11-28
MX9306043A (es) 1994-04-29
ZA937244B (en) 1994-06-27
SG48733A1 (en) 1998-05-18
DK0662837T3 (da) 1999-11-08
HK1008812A1 (en) 1999-05-21
FI951511A0 (fi) 1995-03-30
EP0662837A1 (de) 1995-07-19
MY111543A (en) 2000-08-30
CA2145863A1 (en) 1994-04-28
KR0166663B1 (en) 1999-01-15
ES2131122T3 (es) 1999-07-16
EP0662837B1 (de) 1999-05-19
IL107153A0 (en) 1993-12-28
CZ80495A3 (en) 1996-01-17
CZ286866B6 (en) 2000-07-12
WO1994008606A1 (en) 1994-04-28
NO951240L (no) 1995-05-30
CN1093598A (zh) 1994-10-19
DE69325029D1 (de) 1999-06-24
JP2739770B2 (ja) 1998-04-15
SK281806B6 (sk) 2001-08-06
AU5163593A (en) 1994-05-09
GR3030269T3 (en) 1999-08-31
SK42395A3 (en) 1997-01-08
JPH07507567A (ja) 1995-08-24
HU217871B (hu) 2000-04-28
NO951240D0 (no) 1995-03-30
HU9500933D0 (en) 1995-05-29
FI951511A (fi) 1995-03-30

Similar Documents

Publication Publication Date Title
DE69325029T2 (de) Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
ATE139120T1 (de) Verwendung von rapamycin zur behandlung des diabetes
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
MY104685A (en) Substituted thiazoles and their use as fungicides.
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE3878627T2 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
AU5699494A (en) Novel liquid phenolic antioxidants
ES8205209A1 (es) Un procedimiento para la preparacion de un derivado de ben- zamida
ATE93721T1 (de) Verwendung von fluoxetin zur behandlung des diabetes.
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
DE69103294T2 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.
ATE55265T1 (de) Vorrichtung zur behandlung von schrammen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee